Literature DB >> 16572587

Gene expression profiles of the aurora family kinases.

Yong-Shiang Lin1, Li-Jen Su, Chang-Tze Ricky Yu, Fen-Hwa Wong, Hsu-Hua Yeh, Su-Liang Chen, Jiunn-Chyi Wu, Wey-Jin Lin, Yow-Ling Shiue, Hsiao-Sheng Liu, Shih-Lan Hsu, Jin-Mei Lai, Chi-Ying F Huang.   

Abstract

The evolutionarily conserved Aurora family kinases, a family of mitotic serine/threonine kinases, has three members in humans (Aurora-A, -B and -C). Overexpression of Aurora family members, particularly Aurora-A, has been reported in many human cancers and cell lines. In this study, we present evidence based on comparative gene expression analysis via quantitative RT-PCR to delineate the relative contributions of these kinases in 60 cell lines and statistical analysis in five different human cancer microarray datasets. The analysis demonstrated the selective upregulation of these Aurora members in various cancers. In general, Aurora-A exhibited the highest expression levels, with substantially decreased quantities of the Aurora-C transcript detected relative to Aurora-A and -B. Moreover, to characterize the roles of each Aurora member, which share many similarities, we investigated the expression profiles of the family in normal tissues and a panel of different phases of the HeLa cell cycle. Finally, both Aurora-A and -B were overexpressed in a majority of esophageal tumor tissues in comparison to the normal variants. Taken together, the results show that each Aurora member exhibits distinct expression patterns, implying that they are engaged in different biological processes to accomplish more elaborate cell physiological functions in higher organisms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16572587      PMCID: PMC6032448          DOI: 10.3727/000000006783991962

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  41 in total

Review 1.  Centrosome aberrations: cause or consequence of cancer progression?

Authors:  Erich A Nigg
Journal:  Nat Rev Cancer       Date:  2002-11       Impact factor: 60.716

2.  Large-scale analysis of the human and mouse transcriptomes.

Authors:  Andrew I Su; Michael P Cooke; Keith A Ching; Yaron Hakak; John R Walker; Tim Wiltshire; Anthony P Orth; Raquel G Vega; Lisa M Sapinoso; Aziz Moqrich; Ardem Patapoutian; Garret M Hampton; Peter G Schultz; John B Hogenesch
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

3.  A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines.

Authors:  S Sen; H Zhou; R A White
Journal:  Oncogene       Date:  1997-05-08       Impact factor: 9.867

4.  Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers.

Authors:  Y Miyoshi; K Iwao; C Egawa; S Noguchi
Journal:  Int J Cancer       Date:  2001-05-01       Impact factor: 7.396

5.  20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells.

Authors:  E Savelieva; C D Belair; M A Newton; S DeVries; J W Gray; F Waldman; C A Reznikoff
Journal:  Oncogene       Date:  1997-02-06       Impact factor: 9.867

6.  Human INCENP colocalizes with the Aurora-B/AIRK2 kinase on chromosomes and is overexpressed in tumour cells.

Authors:  R R Adams; D M Eckley; P Vagnarelli; S P Wheatley; D L Gerloff; A M Mackay; P A Svingen; S H Kaufmann; W C Earnshaw
Journal:  Chromosoma       Date:  2001-05       Impact factor: 4.316

7.  Cell cycle-dependent expression and spindle pole localization of a novel human protein kinase, Aik, related to Aurora of Drosophila and yeast Ipl1.

Authors:  M Kimura; S Kotani; T Hattori; N Sumi; T Yoshioka; K Todokoro; Y Okano
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

8.  Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast.

Authors:  T Tanaka; M Kimura; K Matsunaga; D Fukada; H Mori; Y Okano
Journal:  Cancer Res       Date:  1999-05-01       Impact factor: 12.701

9.  The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma.

Authors:  Eiji Tanaka; Yosuke Hashimoto; Tetsuo Ito; Tomoyuki Okumura; Takatsugu Kan; Go Watanabe; Masayuki Imamura; Johji Inazawa; Yutaka Shimada
Journal:  Clin Cancer Res       Date:  2005-03-01       Impact factor: 12.531

10.  Biologic properties of three newly established human esophageal carcinoma cell lines.

Authors:  C P Hu; H G Hsieh; K Y Chien; P Y Wang; C I Wang; C Y Chen; S J Lo; K D Wuu; C M Chang
Journal:  J Natl Cancer Inst       Date:  1984-03       Impact factor: 13.506

View more
  15 in total

Review 1.  Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy.

Authors:  Kinsie E Arnst; Souvik Banerjee; Hao Chen; Shanshan Deng; Dong-Jin Hwang; Wei Li; Duane D Miller
Journal:  Med Res Rev       Date:  2019-02-11       Impact factor: 12.944

2.  Regulation of AURKC expression by CpG island methylation in human cancer cells.

Authors:  Satoshi Fujii; Vibhuti Srivastava; Apurva Hegde; Yutaka Kondo; Lanlan Shen; Koyu Hoshino; Yvette Gonzalez; Jin Wang; Kaori Sasai; Xiaotu Ma; Hiroshi Katayama; Marcos R Estecio; Stanley R Hamilton; Ignacio Wistuba; Jean-Pierre J Issa; Subrata Sen
Journal:  Tumour Biol       Date:  2015-05-20

Review 3.  Mitotic failures in cancer: Aurora B kinase and its potential role in the development of aneuploidy.

Authors:  Katalin Hegyi; Gábor Méhes
Journal:  Pathol Oncol Res       Date:  2012-07-29       Impact factor: 3.201

4.  Preclinical evaluation of the Aurora kinase inhibitors AMG 900, AZD1152-HQPA, and MK-5108 on SW-872 and 93T449 human liposarcoma cells.

Authors:  Sandhya Noronha; Lauren A C Alt; Taylor E Scimeca; Omran Zarou; Justyna Obrzut; Brian Zanotti; Elizabeth A Hayward; Akhil Pillai; Shubha Mathur; Joseph Rojas; Ribhi Salamah; Nalini Chandar; Michael J Fay
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-12-01       Impact factor: 2.416

5.  Aurora kinase-C-T191D is constitutively active mutant.

Authors:  Jabbar Khan; Sanaullah Khan; Sobia Attaullah; Ijaz Ali; Shahid Niaz Khan
Journal:  BMC Cell Biol       Date:  2012-03-26       Impact factor: 4.241

6.  A translational regulator, PUM2, promotes both protein stability and kinase activity of Aurora-A.

Authors:  Yei-Hsuan Huang; Chun-Chi Wu; Chen-Kung Chou; Chi-Ying F Huang
Journal:  PLoS One       Date:  2011-05-11       Impact factor: 3.240

7.  Transcriptional activation of the Axl and PDGFR-α by c-Met through a ras- and Src-independent mechanism in human bladder cancer.

Authors:  Chen-Yun Yeh; Shin-Mei Shin; Hsuan-Heng Yeh; Tsung-Jung Wu; Jyh-Wei Shin; Tsuey-Yu Chang; Giri Raghavaraju; Chung-Ta Lee; Jung-Hsien Chiang; Vincent S Tseng; Yuan-Chii G Lee; Cheng-Huang Shen; Nan-Haw Chow; Hsiao-Sheng Liu
Journal:  BMC Cancer       Date:  2011-04-16       Impact factor: 4.430

8.  Overexpression of active Aurora-C kinase results in cell transformation and tumour formation.

Authors:  Jabbar Khan; Frédéric Ezan; Jean-Yves Crémet; Alain Fautrel; David Gilot; Marine Lambert; Christelle Benaud; Marie-Bérengère Troadec; Claude Prigent
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

9.  Protein phosphorylation profiling using an in situ proximity ligation assay: phosphorylation of AURKA-elicited EGFR-Thr654 and EGFR-Ser1046 in lung cancer cells.

Authors:  Tzu-Chi Chen; Yu-Wen Liu; Yei-Hsuan Huang; Yi-Chen Yeh; Teh-Ying Chou; Yu-Chung Wu; Chun-Chi Wu; Yi-Rong Chen; Hui-Chuan Cheng; Pei-Jung Lu; Jin-Mei Lai; Chi-Ying F Huang
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

10.  Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme.

Authors:  Li-Jen Su; Ching-Wei Chang; Yu-Chung Wu; Kuang-Chi Chen; Chien-Ju Lin; Shu-Ching Liang; Chi-Hung Lin; Jacqueline Whang-Peng; Shih-Lan Hsu; Chen-Hsin Chen; Chi-Ying F Huang
Journal:  BMC Genomics       Date:  2007-06-01       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.